Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLuceco Plc Regulatory News (LUCE)

Share Price Information for Luceco Plc (LUCE)

Share Price is delayed by 15 minutes
Get Live Data
272.00    1.00 (0.37%)
Bid:
271.00
Ask:
272.00
Spread: 1.00 (0.369%)
Market Cap: £400.36m
LUCE Live PriceLast checked at - London Stock Exchange

Intraday Luceco Plc Share Chart

Director/PDMR Shareholding

27 Nov 2018 16:35

RNS Number : 6760I
Luceco PLC
27 November 2018
 

LUCECO PLC (THE "COMPANY")

 

AWARDS UNDER LUCECO 2017 PERFORMANCE SHARE PLAN

 

Grant of an award to Matthew Webb

 

On 21 February 2018 shortly following his appointment, the Company announced that Matthew Webb, the Company's Chief Financial Officer, had been granted an award under the Luceco 2017 Performance Share Plan (the "PSP"). This award was in the form of a nil-cost option in conjunction with a linked tax qualifying option.

 

Due to an administrative error this award was not formally granted to Mr Webb. As the nil-cost option operates in conjunction with a linked tax qualifying option it was not possible to rectify the terms of the award.

 

On 23 November 2018 the Company therefore made a replacement award under the PSP.

 

The award is in the form of a nil-cost option over 729,040 ordinary shares of 0.05 pence in the Company.

In addition Mr Webb has been awarded a linked tax qualifying option over 72,904 shares at an exercise price of 41.15 pence. On exercise the number of shares under the nil-cost option will be reduced proportionally to take account of any gain on the exercise of the tax qualifying option such that Mr Webb will not receive a greater number of shares than is subject to the nil-cost option.

 

The award will vest subject to the satisfaction of performance conditions measuring the Company's earnings per share and total shareholder return performance. Earnings per share will be measured over the three financial years from 1 January 2018 to 31 December 2020. Total shareholder return will be measured over the three year period from 23 November 2018 to 22 November 2021.

 

No consideration was paid for the award.

 

The Remuneration Committee of the Company believes that making this award to Mr Webb is in the best interests of the Company.

 

Surrender of a PSP Award by John Hornby

 

On 27 November 2018, John Hornby, the Company's Chief Executive Officer, surrendered the award granted to him under the PSP on 27 July 2018. This award was in the form of a nil-cost option over 431,415 ordinary shares of 0.05 pence in the Company.

 

This notification is made in accordance with the Market Abuse Regulation ("MAR"). Template notifications required by the MAR are attached to this announcement.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Matt Webb

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Luceco PLC

b)

LEI

213800BBFZK4W4P98U76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of £0.0005

 

GB00BZC0LP49

b)

Nature of transaction

An award of Ordinary Shares made under the Luceco PLC Performance Share Plan ("PSP") on 23 November 2018 in the form of 1) a nil-cost option and 2) a linked tax qualifying option

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1: nil

2: £0.4115

1: 729,040

2: 72,904

d)

Aggregated information

- Aggregated volume

- Price

 

N/A

e)

Date of the transaction

23/11/2018

f)

Place of the transaction

Outside a trading venue (XOFF)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBLBDBXXDBGIR
Date   Source Headline
28th May 20262:56 pmRNSHolding(s) in Company
27th May 20265:56 pmRNSDirector/PDMR Shareholding
27th May 20262:41 pmRNSDirector/PDMR Shareholding
22nd May 20261:16 pmRNSHolding(s) in Company
19th May 20263:35 pmRNSResult of AGM
19th May 20267:00 amRNSQ1 2026 Trading Update
7th May 20263:08 pmRNSDirector/PDMR Shareholding
27th Apr 202611:14 amRNSMarket Purchase of Shares for EBT
24th Apr 20266:03 pmRNSHolding(s) in Company
20th Apr 20264:18 pmRNSNotice of AGM
20th Apr 20267:01 amRNSDirector Declaration
9th Apr 20265:20 pmRNSDirector/PDMR Shareholding
31st Mar 20265:29 pmRNSChange in Directorate Roles and Responsibilities
25th Mar 20267:00 amRNS2025 Full Year Results
19th Feb 20265:54 pmRNSHolding(s) in Company
17th Feb 20263:58 pmRNSHolding(s) in Company
13th Feb 20265:30 pmRNSHolding(s) in Company
13th Feb 20267:00 amRNSAppointment of Joint Corporate Broker
9th Feb 202612:03 pmRNSDirector/PDMR Shareholding
9th Feb 202611:11 amRNSHolding(s) in Company
29th Jan 20267:00 amRNS2025 Full Year Trading Update
9th Dec 20254:00 pmRNSAppointment of Non-Executive Director
8th Dec 20254:30 pmRNSHolding(s) in Company
4th Dec 20255:00 pmRNSHolding(s) in Company
12th Nov 20255:00 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSQ3 2025 Trading Update
23rd Oct 20252:10 pmRNSHolding(s) in Company
21st Oct 20254:34 pmRNSHolding(s) in Company
7th Oct 20253:53 pmRNSHolding(s) in Company
15th Sep 20255:00 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNS2025 Interim Results
6th Aug 20254:08 pmRNSHolding(s) in Company
5th Aug 20254:19 pmRNSHolding(s) in Company
5th Aug 20254:17 pmRNSDirector/PDMR Shareholding
5th Aug 20251:08 pmRNSHolding(s) in Company
23rd Jul 20253:59 pmRNSHolding(s) in Company
22nd Jul 20257:00 amRNSH1 2025 Trading Update
21st Jul 20254:31 pmRNSAppointment of Audit Committee Chair
8th Jul 20253:49 pmRNSDirector Declaration
28th May 20255:30 pmRNSDirector/PDMR Shareholding
20th May 20251:55 pmRNSResult of AGM
20th May 20257:00 amRNSQ1 2025 Trading Update
16th May 20253:41 pmRNSHolding(s) in Company
14th May 20254:43 pmRNSHolding(s) in Company
8th May 20259:50 amRNSDirector/PDMR Shareholding
15th Apr 202511:21 amRNSNotice of AGM
11th Apr 20254:34 pmRNSDirector/PDMR Shareholding
9th Apr 20253:35 pmRNSGrant of Awards Under Performance Share Plan
26th Mar 20257:00 amRNS2024 Full Year Results
11th Mar 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.